| Title: |
Interim 2024/25 influenza vaccine effectiveness: eight European studies, September 2024 to January 2025 / |
| Authors: |
Rose, Angela MC; Lucaccioni, Héloïse; Marsh, Kimberly; Kirsebom, Freja; Whitaker, Heather; Emborg, Hanne-Dorthe; Bolt Botnen, Amanda; O’Doherty, Mark G; Pozo, Francisco; Hameed, Safraj Shahul; Andrews, Nick; Hamilton, Mark; Trebbien, Ramona; Lauenborg Møller, Karina; Marques, Diogo FP; Murphy, Siobhan; McQueenie, Ross; Lopez-Bernal, Jamie; Cottrell, Simon; Bucholc, Magda; Kissling, Esther |
| Contributors: |
Jančorienė, Ligita; Majauskaitė, Fausta; Mickienė, Auksė; Kuliešė, Monika |
| Source: |
Eurosurveillance., Stockholm : European Centre for Disease Control and Prevention (ECDC), 2025, vol. 30, iss. 7, art. no. 2500102, p. [1-11]. ; eISSN 1560-7917 |
| Publication Year: |
2025 |
| Collection: |
Vilnius University Virtual Library (VU VL) / Vilniaus universitetas virtuali biblioteka |
| Description: |
The 2024/25 influenza season in Europe is currently characterised by co-circulation of influenza A(H1N1)pdm09, A(H3N2) and B/Victoria viruses, with influenza A(H1N1)pdm09 predominating. Interim vaccine effectiveness (VE) estimates from eight European studies (17 countries) indicate an all-age influenza A VE of 32–53% in primary care and 33–56% in hospital settings, with some signals of lower VE by subtype and higher VE against influenza B (≥ 58% across settings). Where feasible, influenza vaccination should be encouraged and other prevention measures strengthened. |
| Document Type: |
article in journal/newspaper |
| File Description: |
application/pdf |
| Language: |
English |
| Relation: |
https://epublications.vu.lt/object/elaba:222067920/222067920.pdf; https://repository.vu.lt/VU:ELABAPDB222067920&prefLang=en_US |
| Availability: |
https://repository.vu.lt/VU:ELABAPDB222067920&prefLang=en_US |
| Rights: |
info:eu-repo/semantics/openAccess |
| Accession Number: |
edsbas.A5DA80D2 |
| Database: |
BASE |